FindTrial
Sign In

Comparative study between Chemotherapy via Arterial route in untreated verses previously treated cases of cancer of Eye in Children

Super Selective Intra - Arterial Chemotherapy for Retinoblastoma - A Prospective Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065583
Enrollment
20
Registered
2024-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C692- Malignant neoplasm of retina

Interventions

Intervention1: Primary Intra Arterial Chemotherapy In Retinoblastoma: Patients with Retinoblastoma who receive Intra Arterial Chemotherapy (IAC) as primary modality of treatment. Regimens include Sin

Sponsors

Dr Rajendra Prasad Centre for Ophthalmic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Group B/ Group C / Group D Retinoblastoma (International Classification), Fit to undergo GA procedure, Informed Consent

Exclusion criteria

Exclusion criteria: Patients Diagnosed with Group A/ Group E Retinoblastoma (International Classification), Patients with Extraocular Spread / Systemic Metastasis, Patient/ LAR Not Willing for Treatment, Patient/ LAR Not Willing for Follow Up

Design outcomes

Primary

MeasureTime frame
Globe Salvage RateTimepoint: 4 WEEKS, 8 WEEKS, 12 WEEKS, 16 WEEKS, 20 WEEKS, 24 WEEKS—

Secondary

MeasureTime frame
Procedure Failure RateTimepoint: 4 WEEKS, 8 WEEKS, 12 WEEKS, 16 WEEKS, 20 WEEKS, 24 WEEKS;Procedure Success RateTimepoint: 4 WEEKS, 8 WEEKS, 12 WEEKS, 16 WEEKS, 20 WEEKS, 24 WEEKS;Tumor Control RateTimepoint: 4 WEEKS, 8 WEEKS, 12 WEEKS, 16 WEEKS, 20 WEEKS, 24 WEEKS—

Countries

India

Contacts

Public ContactDR ANIKET LAXMIKANT RAMTEKE

ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI

bhavna2424@hotmail.com9654842424

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026